JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on March 18, 2005
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
280/11/10001    most recent
M410972200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Y.
Right arrow Articles by Platanias, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Y.
Right arrow Articles by Platanias, L. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print January 11, 2005
J. Biol. Chem, 10.1074/jbc.M410972200
Submitted on September 23, 2004
Revised on January 11, 2005
Accepted on January 11, 2005

Activation of Mkk3 and Mkk6 by type I interferons

Yongzhong Li, Sandeep Batra, Antonella Sassano, Beata Majchrzak, David E. Levy, Matthias Gaestel, Eleanor N. Fish, Roger J. Davis, and Leonidas C. Platanias

Robert H. Lurie Comprehensive Cancer Center, Northwestern University Medical School, Chicago, IL 60611

Corresponding Author: l-platanias{at}northwestern.edu

There is accumulating evidence that the p38 Map kinase pathway plays important roles in Type I interferon (IFN) signaling, but the mechanisms regulating p38 activation during engagement of the Type I IFN receptor remain to be defined. We sought to identify the events that lead to activation of the p38 Map kinase in response to Type I IFNs. Our data demonstrate that treatment of sensitive cell lines with IFN-alfa results in activation of both Map kinase kinase 3 (Mkk3) and Map kinase kinase 6 (Mkk6). Such IFN-inducible activation of Mkk3 and Mkk6 is essential for downstream phosphorylation and activation of the p38 Map kinase, as shown by studies using mouse embryonic fibroblasts (MEFs) with targeted disruption of the Mkk3 and Mkk6 genes (Mkk3-/-Mkk6-/-). Similarly, IFN-dependent activation of the downstream effectors of p38, MapKapK-2 and MapKapK-3, is not detectable in cells lacking Mkk3 and Mkk6, demonstrating that the function of these Map kinase kinases is required for full activation of the p38-pathway. To define the functional relevance of Mkk3/6 engagement in Type I IFN signaling, IFN-inducible gene transcription was evaluated in the Mkk3/Mkk6 double knockout cells. IFN alfa- and IFN beta-dependent transcription via either ISRE or GAS elements was defective in Mkk3 -/-Mkk6 -/- MEFs in luciferase reporter assays. In addition, IFN-dependent induction of two genes known to be of importance in the generation of IFN-responses, ISG15 and IRF-9, was diminished in the absence of Mkk3 and Mkk6. The effects of Mkk3 and Mkk6 on IFN-dependent transcription were unrelated to any effects on the phosphorylation and activation of Stat-proteins, indicating the presence of a Stat-independent mechanism. Altogether, our findings demonstrate that Mkk3 and Mkk6 are rapidly activated during engagement of the Type I IFN receptor and play important roles in Type I IFN-signaling and the generation of IFN-responses.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Dent. Res.Home page
J.F. Schindler, J.B. Monahan, and W.G. Smith
p38 Pathway Kinases as Anti-inflammatory Drug Targets
J. Dent. Res., September 1, 2007; 86(9): 800 - 811.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. S. Dunn, T. J. Haggerty, M. Kono, P. J. Durda, D. Butera, D. B. Macdonald, E. M. Benson, L. B. Rose, and J. T. Kurnick
Enhancement of Human Melanoma Antigen Expression by IFN-beta
J. Immunol., August 15, 2007; 179(4): 2134 - 2142.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.